Related references
Note: Only part of the references are listed.Methamphetamine and its immune-modulating effects
Marco Papageorgiou et al.
MATURITAS (2019)
Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies
Milky Kohno et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
The Main Molecular Mechanisms Underlying Methamphetamine-Induced Neurotoxicity and Implications for Pharmacological Treatment
Xue Yang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Pharmacotherapy for amphetamine dependence: A systematic review
Nicole K. Lee et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
R. J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Methamphetamine neurotoxicity, microglia, and neuroinflammation
Fatemeh Shaerzadeh et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Pharmacotherapeutic agents in the treatment of methamphetamine dependence
Kirsten C. Morley et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Clinical Characteristics, Histopathological Features, and Clinical Outcome of Methamphetamine-Associated Cardiomyopathy
Stephan Schuerer et al.
JACC-HEART FAILURE (2017)
Ibudilast may improve attention during early abstinence from methamphetamine
J. Brandon Birath et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Parkinson's disease: Autoimmunity and neuroinflammation
Armando De Virgilio et al.
AUTOIMMUNITY REVIEWS (2016)
Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study
Matthew J. Worley et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment
Dustin Z. DeYoung et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models
Virawudh Soontornniyomkij et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
Bupropion for the treatment of methamphetamine dependence in non-daily users: A randomized, double-blind, placebo-controlled trial
Ann L. Anderson et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use
Keith G. Heinzerling et al.
ADDICTION (2014)
Glial cell modulators attenuate methamphetamine self-administration in the rat
Sarah E. Snider et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment
Matthew Brensilver et al.
DRUG AND ALCOHOL REVIEW (2013)
The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice
Sarah E. Snider et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Methamphetamine Causes Persistent Immune Dysregulation: A Cross-Species, Translational Report
Jennifer M. Loftis et al.
NEUROTOXICITY RESEARCH (2011)
Role of Astrocytes in Brain Function and Disease
Marta Sidoryk-Wegrzynowicz et al.
TOXICOLOGIC PATHOLOGY (2011)
A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period
Adam Bisaga et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence
Keith G. Heinzerling et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse
Patrick M. Beardsley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Ibudilast in relapsing-remitting multiple sclerosis A neuroprotectant?
F. Barkhof et al.
NEUROLOGY (2010)
Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
Yoonsang Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Modafinil for the treatment of cocaine dependence
Ann L. Anderson et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease
P. Rolan et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Implication of Activated Astrocytes in the Development of Drug Dependence Differences between Methamphetamine and Morphine
Minoru Narita et al.
ADDICTION REVIEWS 2008 (2008)
The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity
David M. Thomas et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Methamphetamine causes microglial activation in the brains of human abusers
Yoshimoto Sekine et al.
JOURNAL OF NEUROSCIENCE (2008)
A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse
W. E. Fantegrossi et al.
NEUROSCIENCE (2008)
The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family
Lucien C. D. Gibson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
A structured approach to medical management: A psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence
HM Pettinati et al.
JOURNAL OF STUDIES ON ALCOHOL (2005)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation
L Minghetti et al.
BRAIN RESEARCH REVIEWS (2005)
Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine
DM Thomas et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Utility of lead-in period in cocaine dependence pharmacotherapy trials
A Bisaga et al.
DRUG AND ALCOHOL DEPENDENCE (2005)
Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia
T Mizuno et al.
NEUROPHARMACOLOGY (2004)
Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat
H Wakita et al.
BRAIN RESEARCH (2003)
Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6
B Ladenheim et al.
MOLECULAR PHARMACOLOGY (2000)
Share Paper
